» Articles » PMID: 27066902

Plasmodium Copy Number Variation Scan: Gene Copy Numbers Evaluation in Haploid Genomes

Overview
Journal Malar J
Publisher Biomed Central
Specialty Tropical Medicine
Date 2016 Apr 13
PMID 27066902
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In eukaryotic genomes, deletion or amplification rates have been estimated to be a thousand more frequent than single nucleotide variation. In Plasmodium falciparum, relatively few transcription factors have been identified, and the regulation of transcription is seemingly largely influenced by gene amplification events. Thus copy number variation (CNV) is a major mechanism enabling parasite genomes to adapt to new environmental changes.

Methods: Currently, the detection of CNVs is based on quantitative PCR (qPCR), which is significantly limited by the relatively small number of genes that can be analysed at any one time. Technological advances that facilitate whole-genome sequencing, such as next generation sequencing (NGS) enable deeper analyses of the genomic variation to be performed. Because the characteristics of Plasmodium CNVs need special consideration in algorithms and strategies for which classical CNV detection programs are not suited a dedicated algorithm to detect CNVs across the entire exome of P. falciparum was developed. This algorithm is based on a custom read depth strategy through NGS data and called PlasmoCNVScan.

Results: The analysis of CNV identification on three genes known to have different levels of amplification and which are located either in the nuclear, apicoplast or mitochondrial genomes is presented. The results are correlated with the qPCR experiments, usually used for identification of locus specific amplification/deletion.

Conclusions: This tool will facilitate the study of P. falciparum genomic adaptation in response to ecological changes: drug pressure, decreased transmission, reduction of the parasite population size (transition to pre-elimination endemic area).

Citing Articles

Low prevalence of copy number variation in pfmdr1 and pfpm2 in Plasmodium falciparum isolates from southern Angola.

Duarte D, Manuel F, Dias A, Sacato E, Taleingue E, Daniel E Malar J. 2025; 24(1):5.

PMID: 39794826 PMC: 11720348. DOI: 10.1186/s12936-024-05240-2.


Plasmodium falciparum surf4.1 in clinical isolates: From genetic variation and variant diversity to in silico design immunopeptides for vaccine development.

Noranate N, Sripanomphong J, Mphande-Nyasulu F, Chaorattanakawee S PLoS One. 2025; 19(12):e0312091.

PMID: 39775228 PMC: 11684625. DOI: 10.1371/journal.pone.0312091.


Copy Number Variations of Plasmodium vivax DBP1, EBP/DBP2, and RBP2b in Ethiopians Who Are Duffy Positive and Duffy Negative.

Pestana K, Ford A, Rama R, Abagero B, Kepple D, Tomida J J Infect Dis. 2024; 230(4):1004-1012.

PMID: 39102894 PMC: 11481331. DOI: 10.1093/infdis/jiae388.


Molecular tools are crucial for malaria elimination.

Gupta H, Sharma S, Gilyazova I, Satyamoorthy K Mol Biol Rep. 2024; 51(1):555.

PMID: 38642192 DOI: 10.1007/s11033-024-09496-4.


Direct long read visualization reveals metabolic interplay between two antimalarial drug targets.

Liu S, Ebel E, Luniewski A, Zulawinska J, Simpson M, Kim J bioRxiv. 2023; .

PMID: 36824743 PMC: 9948948. DOI: 10.1101/2023.02.13.528367.


References
1.
Coulson R, Hall N, Ouzounis C . Comparative genomics of transcriptional control in the human malaria parasite Plasmodium falciparum. Genome Res. 2004; 14(8):1548-54. PMC: 509263. DOI: 10.1101/gr.2218604. View

2.
Duraisingh M, Cowman A . Contribution of the pfmdr1 gene to antimalarial drug-resistance. Acta Trop. 2005; 94(3):181-90. DOI: 10.1016/j.actatropica.2005.04.008. View

3.
Shaffer L, Lupski J . Molecular mechanisms for constitutional chromosomal rearrangements in humans. Annu Rev Genet. 2000; 34:297-329. DOI: 10.1146/annurev.genet.34.1.297. View

4.
Fassbinder-Orth C . Methods for quantifying gene expression in ecoimmunology: from qPCR to RNA-Seq. Integr Comp Biol. 2014; 54(3):396-406. DOI: 10.1093/icb/icu023. View

5.
Roper C, Alifrangis M, Ariey F, Talisuna A, Menard D, Mercereau-Puijalon O . Molecular surveillance for artemisinin resistance in Africa. Lancet Infect Dis. 2014; 14(8):668-670. DOI: 10.1016/S1473-3099(14)70826-6. View